Cancer Biology


    Protocols in Current Issue
    Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations
    Authors:  Bernd B. Zeisig, Tsz Kan Fung, Estelle Troadec and Chi Wai Eric So, date: 12/20/2021, view: 1665, Q&A: 0

    Acute myeloid leukaemia (AML) is a highly heterogenous blood cancer, in which the expansion of aberrant myeloid blood cells interferes with the generation and function of normal blood cells. Although key driver mutations and their associated inhibitors have been identified in the last decade, they have not been fully translated into better


    We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.